Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)

v3.21.1
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Series E-1 Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid In Capital [Member]
Deferred Stock-based Compensation [Member]
Subscription Receivable [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2019   $ 208 $ 6,475,667 $ (11,049,210) $ (4,573,335)
Balance, shares at Dec. 31, 2019   2,079,898          
Stock-based compensation for services   $ 500 49,500 (29,167) 20,833
Stock-based compensation for services, shares   200,000          
Stock-based compensation expense and stock option modification   24,327 24,327
Series A, preferred stock contractual dividends   (8,317) (8,317)
Balance at Mar. 31, 2020   $ 708 6,541,177 (29,167) (11,486,612) (4,973,893)
Balance, shares at Mar. 31, 2020   2,279,898          
Balance at Dec. 31, 2020 $ 1,947 11,021,840 (148,333) (25,000) (15,911,895) (5,061,441)
Balance, shares at Dec. 31, 2020 281 19,472,241          
Stock-based compensation for services $ 25 537,367 115,000 652,392
Stock-based compensation for services, shares 250,000          
Conversion of debentures and accrued expenses $ 64 515,004 515,068
Conversion of debentures and accrued expenses, shares 632,995          
Conversion of bridge notes and accrued interest to common stock $ 663 4,377,825 4,378,488
Conversion of bridge notes and accrued interest to common stock, shares 6,627,692          
Conversion of Series A preferred stock to common stock $ 75 662,425 (542,500) 120,000
Conversion of Series A preferred stock to common stock, shares 750,000          
Series A, preferred stock contractual dividends   (7,899) (7,899)
Issuance of Series B, preferred stock for cash   $ 2 2,195,998 25,000 2,221,000
Issuance of Series B, preferred stock for cash, shares   2,196          
Conversion of notes with directors to Series B preferred stock and warrants       23,000     23,000
Conversion of notes with directors to Series B preferred stock and warrants, shares   23            
Stock based compensation to employees and directors 6,527,999 (4,141,177) 2,386,223
Stock based compensation to employees and directors, shares 8,500          
Balance at Mar. 31, 2021 $ 1 $ 2 $ 2,774 $ 25,853,559 $ (4,175,110) $ 20,860,452 $ 820,774
Balance, shares at Mar. 31, 2021 8,500 2,500 27,732,928